Advanced search

Synthesis, in vitro and in vivo evaluation of 3β-[18F]fluorocholic acid, a radiolabeled bile acid to detect drug-induced cholestasis in preclinical drug development.

Stef De Lombaerde (UGent) , Sara Neyt (UGent) , Ken Kersemans (UGent) , Jeroen Verhoeven (UGent) , Lindsey Devisscher (UGent) , Hans Van Vlierberghe (UGent) , Christian Vanhove (UGent) and Filip De Vos (UGent)
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
De Lombaerde, Stef, Sara Neyt, Ken Kersemans, Jeroen Verhoeven, Lindsey Devisscher, Hans Van Vlierberghe, Christian Vanhove, and Filip De Vos. 2017. “Synthesis, in Vitro and in Vivo Evaluation of 3β-[18F]fluorocholic Acid,  a Radiolabeled Bile Acid to Detect Drug-induced Cholestasis in Preclinical Drug Development.” In 18th Symposium of the Belgian Society of Nuclear Medicine, 5th to 7th May 2017, Ghent, 140–141. Belgian Society of Nuclear Medicine (BELNUC).
APA
De Lombaerde, S., Neyt, S., Kersemans, K., Verhoeven, J., Devisscher, L., Van Vlierberghe, H., Vanhove, C., et al. (2017). Synthesis, in vitro and in vivo evaluation of 3β-[18F]fluorocholic acid,  a radiolabeled bile acid to detect drug-induced cholestasis in preclinical drug development. 18th Symposium of the Belgian Society of Nuclear Medicine, 5th to 7th May 2017, Ghent (pp. 140–141). Presented at the 18th Symposium of the Belgian Society of Nuclear Medicine (BELNUC), Belgian Society of Nuclear Medicine (BELNUC).
Vancouver
1.
De Lombaerde S, Neyt S, Kersemans K, Verhoeven J, Devisscher L, Van Vlierberghe H, et al. Synthesis, in vitro and in vivo evaluation of 3β-[18F]fluorocholic acid,  a radiolabeled bile acid to detect drug-induced cholestasis in preclinical drug development. 18th Symposium of the Belgian Society of Nuclear Medicine, 5th to 7th May 2017, Ghent. Belgian Society of Nuclear Medicine (BELNUC); 2017. p. 140–1.
MLA
De Lombaerde, Stef, Sara Neyt, Ken Kersemans, et al. “Synthesis, in Vitro and in Vivo Evaluation of 3β-[18F]fluorocholic Acid,  a Radiolabeled Bile Acid to Detect Drug-induced Cholestasis in Preclinical Drug Development.” 18th Symposium of the Belgian Society of Nuclear Medicine, 5th to 7th May 2017, Ghent. Belgian Society of Nuclear Medicine (BELNUC), 2017. 140–141. Print.
@inproceedings{8522278,
  articleno    = {abstract PHARM 03},
  author       = {De Lombaerde, Stef and Neyt, Sara and Kersemans, Ken and Verhoeven, Jeroen and Devisscher, Lindsey and Van Vlierberghe, Hans and Vanhove, Christian and De Vos, Filip},
  booktitle    = {18th Symposium of the Belgian Society of Nuclear Medicine, 5th to 7th May 2017, Ghent},
  language     = {eng},
  location     = {Ghent, Belgium},
  pages        = {abstract PHARM 03:140--abstract PHARM 03:141},
  publisher    = {Belgian Society of Nuclear Medicine (BELNUC)},
  title        = {Synthesis, in vitro and in vivo evaluation of 3\ensuremath{\beta}-[18F]fluorocholic acid,  a radiolabeled bile acid to detect drug-induced cholestasis in preclinical drug development.},
  year         = {2017},
}